The fourth presentation in #ERA24 LBCT1 session is a very passionate one on 🥁Autoantibodies Targeting Nephrin in Podocytopathies 🥁By Tobias B. Huber Tobias B. Huber International Society of Glomerular Disease Another NEJM worthy trial

Presented at #ERA24: Antinephrin autoantibodies occur in adults with minimal change disease and children with idiopathic nephrotic syndrome and appear to be disease activity markers. Their binding at slit diaphragms may induce podocyte dysfunction. nej.md/3UU5o9u

⭐️Our second NEJM published trial of the day #ERA24 Tobias B. Huber International Society of Glomerular Disease x.com/NEJM/status/17…

Forschende des #UKEHamburg haben Ursachen, Auslöser und Krankheitsmechanismus des idiopathischen nephrotischen Syndroms entschlüsselt und legen den Grundstein für eine personalisierte Therapie und Präzisionsmedizin bei der komplexen Nierenerkrankung: uke.de/allgemein/pres… NEJM

A great honor to work with these amazing scientists! Tobias B. Huber, Nicola M. Tomas, Felicitas Hengel, International Society of Glomerular Disease, #ERA24

Hamburg news: The ⁦CKLab⁩ and collaborators used iCROP-seq to identify TH17 cell plasticity as a potential new therapeutic target in autoimmunity. ⁦HCKH_Hamburg⁩ ⁦UKE Hamburg⁩ ⁦Universität Hamburg⁩ science.org/doi/10.1126/sc…